Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Canis_lupus
|
| gptkbp:affects |
gptkb:Skin
connective tissue |
| gptkbp:associated_with |
pulmonary hypertension
heart issues kidney problems |
| gptkbp:awareness_symbol |
gptkb:butterflies
|
| gptkbp:caused_by |
autoimmune response
|
| gptkbp:color |
purple
|
| gptkbp:complication |
pulmonary fibrosis
gastrointestinal complications skin ulcers calcinosis esophageal dysfunction sclerodactyly cardiac involvement renal crisis |
| gptkbp:diagnosis |
blood tests
clinical examination skin biopsy |
| https://www.w3.org/2000/01/rdf-schema#label |
Scleroderma
|
| gptkbp:influenced_by |
regular exercise
healthy diet stress management skin care routines avoidance of smoking |
| gptkbp:is_organized_by |
gptkb:National_Institute_of_Arthritis_and_Musculoskeletal_and_Skin_Diseases
gptkb:Scleroderma_Foundation gptkb:American_College_of_Rheumatology |
| gptkbp:prevalence |
more common in women
onset typically between ages 30 and 50 |
| gptkbp:public_awareness |
gptkb:June
|
| gptkbp:research_focus |
improving quality of life
understanding pathogenesis developing new treatments |
| gptkbp:risk_factor |
environmental factors
family history certain occupations |
| gptkbp:symptoms |
gptkb:Raynaud's_phenomenon
joint pain shortness of breath digestive issues thickening of the skin |
| gptkbp:treatment |
physical therapy
immunosuppressants medications for symptoms |
| gptkbp:type |
Localized scleroderma
Systemic scleroderma |
| gptkbp:bfsParent |
gptkb:SLE
|
| gptkbp:bfsLayer |
6
|